Virgin Atlantic Cosmic Girl, a repurposed Virgin Atlantic Boeing 747 aircraft carrying a rocket, is parked at Spaceport Cornwall, at Cornwall Airport in Newquay, England, Monday, Jan. 9, 2023. (Ben Birchall/PA via AP)
Hopes were high for Virgin Orbit's LauncherOne mission slated for Monday but an anomaly prevented the rocket from launching into orbit.
In what would have been the the first-ever orbital mission launch from the UK, seemed to be going off without a hitch after Virgin Orbit's 'Cosmic Girl' jet carrier transported the LauncherOne rocket from Cornwall to a drop point located in the Atlantic Ocean outside of Ireland.
In another tweet, the company backtracked that confirmation but details into why the launch into orbit were not available.
The LauncherOne mission set out to launch nine small satellites into orbit, with at least one of them being used to conduct technology demonstration for the UK's Ministry of Defense, according to NASA Spaceflight.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.